Results for tag: "Mismatch Repair Deficiency Drug"

The Mismatch Repair Deficiency (MMR) Drug market is a subset of the Oncology Drugs market. MMR drugs are used to treat cancers caused by a deficiency in the body's ability to repair DNA damage. These drugs target the underlying cause of the cancer, rather than just the symptoms. MMR drugs are used to treat a variety of cancers, including colorectal, endometrial, and ovarian cancers. They are also used to treat Lynch Syndrome, a genetic disorder that increases the risk of certain types of cancer. MMR drugs are typically administered intravenously or orally, and can be used in combination with other treatments such as chemotherapy and radiation. They are often used in combination with other drugs to increase their effectiveness. The MMR Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Merck, Pfizer, AstraZeneca, and Novartis. Other companies in the market include Bristol-Myers Squibb, Roche, and Eli Lilly. Show Less Read more